This clinical trial focuses on children with Iron Deficiency Anemia (IDA), a condition where the body doesn’t have enough iron to produce healthy red blood cells. The study will test two medications: ferumoxytol and iron sucrose, which are both given through intravenous administration (directly into a vein).
The main purpose of this research is to evaluate how safe and effective ferumoxytol is for treating children with iron deficiency anemia or who might develop this condition. During the study, participants will receive either ferumoxytol (two doses of 7 mg of iron per kilogram of body weight, up to 510 mg per dose) or iron sucrose (up to 200 mg daily).
The treatment period lasts 5 days, during which doctors will monitor the children’s response to the medication. They will check various health indicators, including the amount of iron in the blood and how well the body is using it. The study will also look at how the medicine moves through the body and how well it is tolerated by the young patients.



Lithuania
Poland